SCHEMBL4790647

SCHEMBL4790647

CC1(C)OCC(COc2ccccc2C=O)O1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA2 P00918 1/20 0.43
MAPK14 Q16539 10/20 0.42
GLA P06280 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
MAPT P10636 1/20 0.39
HTR1A P08908 2/20 0.38
ADRA1D P25100 2/20 0.38
ADRA1A P35348 2/20 0.38
ADRA1B P35368 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5307972 1.00 ALDH1A1 (0.47) ALDH1A1HPGDHTTSMN1; SMN2CA2
SCHEMBL5307075 1.00 ALDH1A1 (0.47) ALDH1A1HPGDHTTSMN1; SMN2CA2
SCHEMBL1133830 0.88 ALDH1A1 (0.50) ALDH1A1HPGDHTTSMN1; SMN2MAPK14
SCHEMBL27969814 0.85 ALDH1A1 (0.51) ALDH1A1HPGDHTTSMN1; SMN2GLA
SCHEMBL5486128 0.84 ALDH1A1 (0.38) ALDH1A1HPGDHTTSMN1; SMN2CA2
SCHEMBL10338142 0.81 CYP2A6 (0.40) ALDH1A1HPGDSMN1; SMN2CA2MAPK14
SCHEMBL28937430 0.80 ALDH1A1 (0.60) ALDH1A1HPGDHTTSMN1; SMN2GLA
SCHEMBL4367638 0.80 ALDH1A1 (0.60) ALDH1A1HPGDHTTSMN1; SMN2GLA
SCHEMBL1034135 0.80 ALDH1A1 (0.60) ALDH1A1HPGDHTTSMN1; SMN2GLA
SCHEMBL3869457 0.80 ALDH1A1 (0.45) ALDH1A1HPGDSMN1; SMN2CA2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1994031-A1 USE OF ADENOSINE A1 AND/OR DUAL A1/A2B AGONISTS FOR PRODUCTION OF MEDICAMENTS FOR TREATING DISEASES Bayer HealthCare AG (DE) 2008-11-26 EP disclosed
WO-2007101531-A1 USE OF ADENOSINE A1 AND/OR DUAL A1/A2B AGONISTS FOR PRODUCTION OF MEDICAMENTS FOR TREATING DISEASES BAYER HEALTHCARE AG (DE) 2007-09-13 WO disclosed
WO-2007017267-A2 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2007-02-15 WO disclosed